Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2026-01-08 @ 1:36 AM
Study NCT ID:
NCT03404960
Status:
COMPLETED
Last Update Posted:
2025-10-10
First Post:
2017-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy
Sponsor:
University of Pennsylvania
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
828516
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None